81 related articles for article (PubMed ID: 32265096)
1. miR-10b regulated by Twist maintains myofibroblasts activities in oral submucous fibrosis.
Fang CY; Yu CC; Liao YW; Hsieh PL; Ohiro Y; Chu PM; Huang YC; Yu CH; Tsai LL
J Formos Med Assoc; 2020 Jul; 119(7):1167-1173. PubMed ID: 32265096
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol inhibits arecoline-induced fibrotic properties of buccal mucosal fibroblasts via miR-200a activation.
Yang HW; Chun-Yu Ho D; Liao HY; Liao YW; Fang CY; Ng MY; Yu CC; Lin FC
J Dent Sci; 2024 Apr; 19(2):1028-1035. PubMed ID: 38618058
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of Notch Suppresses Epithelial-mesenchymal Transition and Induces Angiogenesis in Oral Submucous Fibrosis by Regulating TGF-β1.
Wang J; Yang L; Mei J; Li Z; Huang Y; Sun H; Zheng K; Kuang H; Luo W
Biochem Genet; 2024 Apr; 62(2):1055-1069. PubMed ID: 37526864
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast activating protein promotes the proliferation, migration, and activation of fibroblasts in oral submucous fibrosis.
Li M; Deng Z; Xie C; Chen J; Yuan Z; Rahhal O; Tang Z
Oral Dis; 2024 Apr; 30(3):1252-1263. PubMed ID: 37357365
[TBL] [Abstract][Full Text] [Related]
5. Exosomes Derived from Human Adipose Mesenchymal Stem Cells Inhibits Fibrosis and Treats Oral Submucous Fibrosis via the miR-181a-5p/Smad2 Axis.
Shao Z; Xu J; Xu X; Wang X; Zhou Y; Li Y; Li K
Tissue Eng Regen Med; 2024 Jan; 21(1):123-135. PubMed ID: 37755664
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of adipose tissue-derived stromal cell-extracellular vesicles in treating oral submucous fibrosis by blocking the TGF-β1/Smad3 pathway via the miR-760-3p/IGF1R axis.
Wang F; Jiang L; Liu P; Jiang Y
Biomol Biomed; 2023 Dec; ():. PubMed ID: 38059910
[TBL] [Abstract][Full Text] [Related]
7. circMTO1/miR-30c-5p/SOCS3 axis alleviates oral submucous fibrosis through inhibiting fibroblast-myofibroblast transition.
Bin X; Cheng JY; Deng ZY; Li B; Xu XH; Liu OS; Tang Z
J Oral Pathol Med; 2024 May; ():. PubMed ID: 38802299
[TBL] [Abstract][Full Text] [Related]
8. Jiawei Danxuan Koukang Alleviates Arecoline Induced Oral Mucosal Lesions: Network Pharmacology and the Combined Ultra-High Performance Liquid Chromatography (UPLC) and Mass Spectrometry (MS).
Zhou L; Tan J; Dai Y; Zhu K; Xiao Y; Wu D; Wang Z; Tan Y; Qin Y
Drug Des Devel Ther; 2023; 17():3085-3101. PubMed ID: 37854130
[TBL] [Abstract][Full Text] [Related]
9. Curcumin relieves arecoline-induced oral submucous fibrosis via inhibiting the LTBP2/NF-κB axis.
Zhang L; Tan J; Liu Y; Luo M
Oral Dis; 2024 May; 30(4):2314-2324. PubMed ID: 37382472
[TBL] [Abstract][Full Text] [Related]
10. Polyphenol-based targeted therapy for oral submucous fibrosis.
Mehta CH; Paliwal S; Muttigi MS; Seetharam RN; Prasad ASB; Nayak Y; Acharya S; Nayak UY
Inflammopharmacology; 2023 Oct; 31(5):2349-2368. PubMed ID: 37106237
[TBL] [Abstract][Full Text] [Related]
11. DPSCs regulate epithelial-T cell interactions in oral submucous fibrosis.
Wang SY; Zhang SJ; Meng HF; Xu HQ; Guo ZX; Yan JF; Gao JL; Niu LN; Wang SL; Jiao K
Stem Cell Res Ther; 2024 Apr; 15(1):113. PubMed ID: 38650025
[TBL] [Abstract][Full Text] [Related]
12. Guideline for the Diagnosis and Clinical Management of Oral Submucous Fibrosis.
;
Chin J Dent Res; 2023 Dec; 26(4):271-285. PubMed ID: 38126373
[TBL] [Abstract][Full Text] [Related]
13. DNA methyltransferase 3A induces the occurrence of oral submucous fibrosis by promoting the methylation of the von Hippel-Lindau.
Kuang H; Yang L; Li Z; Wang J; Zheng K; Mei J; Sun H; Huang Y; Yang C; Luo W
Oral Dis; 2024 May; 30(4):2325-2336. PubMed ID: 37743610
[TBL] [Abstract][Full Text] [Related]
14. A Critical Interpretive Synthesis of the Role of Arecoline in Oral Carcinogenesis: Is the Local Cholinergic Axis a Missing Link in Disease Pathophysiology?
Gocol H; Zeng JH; Chang S; Koh BY; Nguyen H; Cirillo N
Pharmaceuticals (Basel); 2023 Dec; 16(12):. PubMed ID: 38139811
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Oral Fibrinogenesis Through Transforming Growth Factor-Beta/SMAD2/3 Signalling Inhibition Using Mangosteen Pericarp Extract.
P JE; Tn U; Perumal E
Cureus; 2023 Oct; 15(10):e47899. PubMed ID: 38034260
[TBL] [Abstract][Full Text] [Related]
16. Oxidative-protective effect of nuclear receptor coactivator 7 on arecoline-induced endothelial-to-mesenchymal transition.
Wang Y; Luo D; Yuan X; Luo Y; Cheng X; Gao Y; Xie X
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Nov; 130(5):565-573. PubMed ID: 32988808
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin inhibits ROS/NLRP3 inflammatory pathway through FOXO3A to ameliorate oral submucosal fibrosis.
Zeng Y; Luo M; Yao Z; Xiao X
Odontology; 2024 Jan; ():. PubMed ID: 38217790
[TBL] [Abstract][Full Text] [Related]
18. Development of Epigallocatechin 3-gallate-Loaded Hydrogel Nanocomposites for Oral Submucous Fibrosis.
Mehta CH; Velagacherla V; Manandhar S; Nayak Y; Pai SRK; Acharya S; Nayak UY
AAPS PharmSciTech; 2024 Mar; 25(4):66. PubMed ID: 38519779
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of two arecoline-induced oral submucous fibrosis models.
Tang S; Jiang L; Zhou Y; Zhou T; Peng Y; Zhou S; Yue Y; Xia X; Li J; Chen Q; Jiang Y; Feng X
Oral Dis; 2023 Dec; ():. PubMed ID: 38098250
[TBL] [Abstract][Full Text] [Related]
20. Oral Submucous Fibrosis Secondary to Buccal Mucosal Graft for Urethroplasty.
Ansari HM; Rao S; Sharma A; Galhotra V
Indian J Otolaryngol Head Neck Surg; 2022 Dec; 74(Suppl 3):5601-5603. PubMed ID: 36742534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
